# NATCO Pharma Limited, Rangareddy, India – FDA Inspections

Source: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

> Inspection records and compliance data for NATCO Pharma Limited in Rangareddy. 8 FDA inspections on record, 4 Form 483s, last inspected June 19, 2025.

---

## Details

- Name: NATCO Pharma Limited
- FEI Number: 3004540906
- Facility Type: Manufacturer
- Business Operations: FDF MANUFACTURE
- Address Line 1: Pharma Division, Kothur Village
- City: Rangareddy
- Country Name: India
- Address: Pharma Division, Kothur Village, Rangareddy, India
- Country: India

## Related Documents

- [EIR - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/eir/natco-pharma-limited/15752826-391f-4aff-bfa9-bbb8405c68d4) — source: FDA, date: June 19, 2025
- [483 - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/483/natco-pharma-limited/f7f3273d-2be6-4f68-9f8f-a170de0e988e) — source: FDA, date: June 19, 2025
- [FDA Inspection 1273711 - NATCO Pharma Limited - 2025-06-19](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2025
- [483 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/483/natco-pharma-limited/10dc5409-7a8f-438a-84ec-a39ae77c0ab3) — source: FDA, date: October 18, 2023
- [FDA Inspection 1220533 - NATCO Pharma Limited - 2023-10-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/490eaf04-f2ac-48ef-96c9-2879ca06696c) — source: FDA, date: October 18, 2023
- FDA Inspection 1137171 - NATCO Pharma Limited - 2019-06-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 24, 2019
- [FDA Inspection 1095772 - NATCO Pharma Limited - 2019-06-06](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2019
- [483 - NATCO Pharma Limited - 2019-06-05](https://www.keypedia.com/records/483/natco-pharma-limited/0bf5ef08-8bd5-4fcd-a591-64b19920b76d) — source: FDA, date: June 5, 2019
- [483 - NATCO Pharma Limited - 2017-01-24](https://www.keypedia.com/records/483/natco-pharma-limited/2a205475-5923-4695-9193-3ade2ddbebb2) — source: FDA, date: January 24, 2017
- [FDA Inspection 1011854 - NATCO Pharma Limited - 2017-01-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 24, 2017
- FDA Inspection 880454 - NATCO Pharma Limited - 2014-05-23 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 23, 2014
- FDA Inspection 762119 - NATCO Pharma Limited - 2011-11-18 — classification: No Action Indicated (NAI), source: FDA, date: November 18, 2011
- FDA Inspection 569301 - NATCO Pharma Limited - 2009-02-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2009

## Related Companies

- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d)
- [Pfizer Healthcare India Private Limited](https://www.keypedia.com/companies/pfizer-healthcare-india-private-limited/50c6f34f-3ef8-4cd6-bd55-6e1ee280d4f7)
- [Ascent Pharmaceuticals Inc](https://www.keypedia.com/companies/ascent-pharmaceuticals-inc/a6df28ee-9e4e-4fae-8eed-dbe5eb870593)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/4221e8f5-a261-45fc-b9fc-d935bc1f225b)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/de9dc5de-fbea-4a7d-ab5b-a398b6ed442e)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/4fd10a2e-3696-4bd0-82aa-e875143028c0)
- [GRANULES LIFE SCIENCES PRIVATE LIMITED](https://www.keypedia.com/companies/granules-life-sciences-private-limited/434955b0-03c5-4fc0-a6c2-1241872c2974)
- [Modavar Pharmaceuticals](https://www.keypedia.com/companies/modavar-pharmaceuticals/9b63702d-7db4-4738-8b79-5f7fc9cd73d6)
- [Aarkish Pharmaceuticals NJ Inc](https://www.keypedia.com/companies/aarkish-pharmaceuticals-nj-inc/62c50ef6-4542-4051-b9f0-04ba004fb177)
- [Procter & Gamble Manufactura S. de R.L. de C.V.](https://www.keypedia.com/companies/procter-gamble-manufactura-s-de-rl-de-cv/8b78eeab-6efe-4a8d-b98a-c1bfda966646)

## Related Officers

- [SVP Consulting & Operations](https://www.keypedia.com/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)
- [Patric C. Klotzbuecher](https://www.keypedia.com/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e)
- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Saleem A. Akhtar](https://www.keypedia.com/people/saleem-a-akhtar/1ea49212-bea5-4d43-bd0a-cdede4d3b1cf)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
